Skip to main content
Alfred Chang, MD, General Surgery, Ann Arbor, MI, University of Michigan Medical Center

AlfredEChangMD

General Surgery Ann Arbor, MI

Surgical Oncology (Other than Breast)

Professor of Surgery, University Mich Medical School

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chang's full profile

Already have an account?

  • Office

    1500 East Medical Ctr Dr
    B1 Floor Cancer & Geriatrics Ctr Recp E
    Ann Arbor, MI 48109
    Phone+1 734-647-8902
  • Is this information wrong?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1979 - 1982
  • Duke University Hospital
    Duke University HospitalResidency, Surgery, 1974 - 1976
  • Harvard Medical School
    Harvard Medical SchoolClass of 1974

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1987 - 2025
  • PA State Medical License
    PA State Medical License 1979 - 1998
  • MD State Medical License
    MD State Medical License 1977 - 1984
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Immunotherapy for Solid Malignancies
    Immunotherapy for Solid MalignanciesApril 21st, 2019

Grant Support

  • University Of Michigan Surgical Oncology Research Training ProgramNational Cancer Institute2006–2011
  • Immunological MonitoringNational Cancer Institute2006–2010
  • T And B Cell Activation Of Cancer ImmunotherapyNational Cancer Institute2009
  • T Cell Activation For Cancer ImmunotherapyNational Cancer Institute1999–2008
  • T Cell Therapy Of Human Renal Cell CancerNational Cancer Institute1996–2007
  • Research Training In Translational Tumor ImmunologyNational Cancer Institute2005
  • Surgical Oncology Research Training ProgramNational Cancer Institute2004–2005
  • Cellular Vaccines For Cancer TherapyNational Cancer Institute2004–2005
  • Pilot--Gastrointestinal OncologyNational Cancer Institute2001–2002
  • Immune Responses Induced By Tumor-Pulsed Dendritic CellsNational Cancer Institute2001–2002
  • Core--ImmunologyNational Cancer Institute2001–2002
  • Core--Immunologic MonitoringNational Cancer Institute2001–2002
  • Core--CoordinationNational Cancer Institute2001–2002
  • Immunotherapy Of Melanoma With Lymph Node Primed With Gmcsf Gene Transduced CellNational Center For Research Resources1998–2002
  • Dendritic Cells Activated By Gmcsf &Il4 As A Tumor Vaccine In Advanced CancerNational Center For Research Resources1998–2002
  • Immunotherapy Of Malignacy By In Vivo Gene Transfer Into TumorsNational Center For Research Resources1997–2002
  • Cellular Therapy Of Cancer With Tumor Primed Anti CD3 Activated LymphocytesNational Center For Research Resources1996–2002
  • Immune Responses Induced By Gene TransferNational Cancer Institute1997–2000
  • Genetic Approaches For Cancer ImmunotherapyNational Cancer Institute1992–2000
  • Surgical Oncology Training In Tumor ImmunologyNational Cancer Institute1991–2000
  • Immunotherapy Of Melanoma With Activated Lymph Node Cells Primed In VivoNational Center For Research Resources1997
  • IUDR And Radiation Therapy In Treatment Of Head And Neck SarcomasNational Center For Research Resources1996
  • Immunotherapy Of Melanoma Cells Primed In Vivo With Tumor Cells With IL4National Center For Research Resources1996
  • Adoptive Immunotherapy Utilizing T Cells Induced By Gene Modified Human CancersNational Cancer Institute1996
  • Immune Responses To Genetically Modified TumorsNational Cancer Institute1992–1993
  • Adoptive Therapy Of Human Cancer With Sensitized T CellsNational Cancer Institute1990–1992

Professional Memberships

Hospital Affiliations